The Role of Biosimilars in the Treatment of Rheumatic Diseases

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2012-202715
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Role of Biosimilars in the Treatment of Rheumatic Diseases

Clinical pharmacology and therapy
2018English

Biosimilars in the Treatment of Rheumatic Diseases: Pro Et Contra

Clinical pharmacology and therapy
2019English

The Role of Interleukin-4 in Rheumatic Diseases

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

The Role of the Gastrointestinal Tract in the Pathogenesis of Rheumatic Diseases

Best Practice and Research in Clinical Rheumatology
MedicineRheumatology
2016English

Diclofenac in the Treatment of Pain in Patients With Rheumatic Diseases

Reumatologia
RheumatologyAllergyImmunology
2018English

Biosimilars in Gastroenterology- An Important Moment in the Treatment of Inflammatory Bowel Diseases

International Journal of Gastroenterology Disorders & Therapy
2016English

Role of Semaphorins in Immunopathologies and Rheumatic Diseases

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Textbook of the Rheumatic Diseases

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1965English

Textbook of the Rheumatic Diseases

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1948English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy